Pharmaceuticals news FT.com

Former UK IPO star Nanopore admits it is a takeover target

DNA sequencing specialist’s decision to list in London in 2021 was seen as a victory for the market at the time

Mar 21, 2025 - 06:04
 0
Former UK IPO star Nanopore admits it is a takeover target
DNA sequencing specialist’s decision to list in London in 2021 was seen as a victory for the market at the time
Read More

Tags:

Previous Article

‘Snow White’ remake drags Disney back into the culture wars

Next Article

Women in UK face HRT treatment ‘lottery’, doctors warn

Related Posts

The big haul

The big haul

Feb 9, 2025  0

GSK proposes raising chief’s pay to as much as £21.6mn a year

GSK proposes raising chief’s pay to as much as £21.6mn ...

Feb 27, 2025  0

Drugmakers prepare to sue EU over tax to pay for wastewater clean-up

Drugmakers prepare to sue EU over tax to pay for wastew...

Mar 3, 2025  0